It's not quite factually correct. The task force was asked to review SIF proposals and international candidates. As Joanne mentioned, CanSino Biologics was one of a number. There were 19 international companies looked at. There were 24 Canadian companies that were examined. CanSino was in that mix. They were reviewed initially by the task force. Further evidence was provided and the task force ruled and their advice to ministers was that new science suggested not backing CanSino further.
The relationship between the National Research Council and CanSino was entirely independent of anything that the task force was doing. The early relationship you were talking about was independent of the task force's advice.